Showing 2501-2510 of 9285 results for "".
Ensuring Equity for Your Patients
https://practicaldermatology.com/series/the-practical-dermatology-podcast/ensuring-equity-for-your-patients/54335/Jeanine Downie, MD, FAAD, and an expert panel discuss implicit bias and discrimination against various marginalized populations and how to be proactive in avoiding these problems in your practice. Joining Dr. Downie are Drs. Mona Gohara, Anthony Rossi, Jacob Beer, and Jane Yoo. This discussion is baNonsurgical Skin Tightening and Facelifts
https://practicaldermatology.com/series/c-suite-chats/nonsurgical-skin-tightening-and-facelifts/54266/Kim Laudati, founder and president of SomaCell, discusses recent demand for minimally invasive, natural-looking treatments and how her company's nonsurgical skin tightening and facelifts help address that trend.DWTV Extra: Skin and Scalp Health
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-skin-and-scalp-health/54147/Chesahna Kindred, MD, MBA, FAAD, discusses an event at the Science of Skin & Scalp Studio in New York, New York, featuring interactive rooms led by dermatologists, beauty experts, and influencers living with chronic inflammatory conditions sharing stories and shaping the conversation around skinEffector Cell Response Inhibitors
https://practicaldermatology.com/series/c-suite-chats/effector-cell-response-inhibitors/48960/Excellergy cofounder Alexander Eggel, PhD, and CEO Todd Zavodnick discuss a recent Journal of Allergy and Clinical Immunology article validating the trifunctional mechanism of action of effector cell response inhibitors (ECRIs) for the treatment of allergic diseases, including chronic spontaneous urImproving Care Options for CTCL
https://practicaldermatology.com/series/c-suite-chats/improving-care-options-for-ctcl/48714/Greg Palko, Vice President, North America, and Oncology Franchise Head for Kyowa Kirin, discusses the challenges posed by cutaneous T-cell lymphoma and efforts to address those issues.The Evolving Needs of the Modern Patient
https://practicaldermatology.com/series/c-suite-chats/the-evolving-needs-of-the-modern-patient/39900/Cutera CEO Taylor Harris talks about the rise of the "multimodality patient," the increasing desire among patients to take control of their healthcare journey, and the rise of regenerative aesthetics, as well as how Cutera is addressing those needs.Dermwire TV: Socioeconomic Neighborhood Status Linked with HS Severity, Plus More
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-socioeconomic-neighborhood-status-linked-with-hs-severity-plus-more/39881/This episode highlights new data linking neighborhood socioeconomic status to hidradenitis suppurativa severity, as well as a new study of mitochondrial decline in skin cells leading to skin aging and even obesity. Also, a new Atopic Dermatitis Journal Club examines combination therapy with dupilumaDWTV Extra: Rocatinlimab Trials
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-rocatinlimab-trials/39044/Clinical investigator Emma Guttman-Yassky, MD, PhD, discusses two sets of data presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025. The phase 3 ROCKET-Ignite Trial evaluated the efficacy and safety of OX40-receptor targeting with rocatinlimab in moderate-to-severe aRegenerative Treatments in Dermatology
https://practicaldermatology.com/series/c-suite-chats/regenerative-treatments-in-dermatology/37707/John Aylworth, PhD, CEO and founder of Xytogen Biotech, talks about the growing demand for regenerative treatments in dermatology and new options for the treatment room.What’s New in Rosacea Treatments?
https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39737/James Q. Del Rosso, DO, FAOCD, reviews the latest therapeutic innovations and evidence in rosacea management. This video was recorded at the Science of Skin Summit in Austin, TX.